Resectable pancreatic cancer needs surgery, then chemotherapy

被引：2
|
作者：
Gottlieb, S
机构：
来源：
BRITISH MEDICAL JOURNAL | 2004年 / 328卷 / 7441期
关键词：
D O I：
10.1136/bmj.328.7441.661-a
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：661 / 661
页数：1
相关论文
共 50 条
  • [31] Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
    Birkmann, Josef
    Wilhelm, Martin
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (12) : 742 - 743
  • [32] NEOADJUVANT THERAPY VERSUS SURGERY FIRST FOR RESECTABLE PANCREATIC CANCER
    Almerey, Tariq
    Hyman, David
    Li, Zhuo
    Tice, Mary
    Porrazzo, Gina
    Stauffer, John
    GASTROENTEROLOGY, 2023, 164 (06) : S1538 - S1538
  • [33] Preoperative Chemoradiotherapy, Surgery and Adjuvant Therapy for Resectable Pancreatic Cancer
    Eguchi, Hidetoshi
    Nagano, Hiroaki
    Tanemura, Masahiro
    Takeda, Yutaka
    Marubashi, Shigeru
    Kobayashi, Shogo
    Kawamoto, Koichi
    Wada, Hiroshi
    Hama, Naoki
    Akita, Hirofumi
    Mori, Masaki
    Doki, Yuichiro
    HEPATO-GASTROENTEROLOGY, 2013, 60 (124) : 904 - 911
  • [34] Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
    Cunningham, David
    Allum, William H.
    Stenning, Sally P.
    Thompson, Jeremy N.
    Van de Velde, Cornelis J. H.
    Nicolson, Marianne
    Scarffe, J. Howard
    Lofts, Fiona J.
    Falk, Stephen J.
    Iveson, Timothy J.
    Smith, David B.
    Langley, Ruth E.
    Verma, Monica
    Weeden, Simon
    Chua, Yu Jo
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01): : 11 - 20
  • [35] Outcomes of Patients with Borderline Resectable Pancreatic Cancer Treated with Combination Chemotherapy
    Shaina Templeton
    Michael Moser
    Chris Wall
    John Shaw
    Haji Chalchal
    Yigan Luo
    Adnan Zaidi
    Shahid Ahmed
    Journal of Gastrointestinal Cancer, 2021, 52 : 529 - 535
  • [36] Chemotherapy for resectable and advanced pancreatic cancer - The Berlin/Rothenberg article reviewed
    Leu, KM
    Zalupski, MM
    ONCOLOGY-NEW YORK, 2001, 15 (10): : 1259 - 1260
  • [37] Postoperative Complications Reduce Adjuvant Chemotherapy Use in Resectable Pancreatic Cancer
    Merkow, R. P.
    Bilimoria, K. Y.
    Tomlinson, J. S.
    Paruch, J. L.
    Stewart, A.
    Winchester, D.
    Ko, C. Y.
    Bentrem, D. J.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S27 - S28
  • [38] Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
    Roberto Alva-Ruiz
    Lavanya Yohanathan
    Jennifer A. Yonkus
    Amro M. Abdelrahman
    Lindsey A. Gregory
    Thorvadur R. Halfdanarson
    Amit Mahipal
    Robert R. McWilliams
    Wen Wee Ma
    Christopher L. Hallemeier
    Rondell P. Graham
    Travis E. Grotz
    Rory L. Smoot
    Sean P. Cleary
    David M. Nagorney
    Michael L. Kendrick
    Mark J. Truty
    Annals of Surgical Oncology, 2022, 29 : 1579 - 1591
  • [39] SURVIVAL OF RESECTABLE PANCREATIC CANCER: THE IMPACT OF POST-OPERATIVE CHEMOTHERAPY
    Syed, Aslam
    Carleton, Neil M.
    Dhawan, Annika
    Horne, Zachary
    Kochhar, Gursimran
    Morrissey, Suzanne
    Williams, Harry K.
    Atkinson, Donald
    Schiffman, Suzanne
    Monga, Dulabh
    Lupetin, Anthony
    Kirichenko, Alexander
    Mitre, Marcia
    Dhawan, Manish K.
    Kulkarni, Abhijit
    Thakkar, Shyam
    GASTROENTEROLOGY, 2019, 156 (06) : S755 - S755
  • [40] Should gemcitabine be used as adjuvant chemotherapy in patients with resectable pancreatic cancer?
    O'Neil, Bert H.
    Goldberg, Richard M.
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2007, 4 (07): : 362 - 363
12345